Global Precision Oncology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Precision Oncology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Precision Oncology market size was valued at USD 98260 million in 2022 and is forecast to a readjusted size of USD 184270 million by 2029 with a CAGR of 9.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.

Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.

This report is a detailed and comprehensive analysis for global Precision Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Precision Oncology market size and forecasts, in consumption value ($ Million), 2018-2029

Global Precision Oncology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Precision Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Precision Oncology market shares of main players, in revenue ($ Million), 2018-2023.

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Precision Oncology

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace.

This report profiles key players in the global Precision Oncology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Acrivon Therapeutics, Bio-Serv, Exact Sciences Corporation, Illumina, Inc. and Invitae Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Precision Oncology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Diagnostics
Therapeutics

Market segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies

Market segment by players, this report covers
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Precision Oncology product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Precision Oncology, with revenue, gross margin and global market share of Precision Oncology from 2018 to 2023.

Chapter 3, the Precision Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Precision Oncology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Precision Oncology.

Chapter 13, to describe Precision Oncology research findings and conclusion.